CPT code 10021: Fine needle aspiration biopsy

Key Takeaways

CPT code 10021 describes fine needle aspiration biopsy without imaging guidance for the first lesion, effective January 1, 2019.

Bill one unit per lesion, not per needle pass. CPT 10004 is the add-on code for each additional lesion when no imaging is used.

CPT 10022 was deleted on January 1, 2019. Imaging-guided FNA now uses codes 10005-10012 based on imaging modality and lesion count.

Pabau’s claims management software supports accurate CPT code tracking and documentation workflows for FNA billing.

Fine needle aspiration biopsy, often abbreviated FNA or FNAB, uses a thin hollow needle to collect cells or fluid from a palpable mass or cyst for cytopathology. CPT code 10021 is the FNA CPT code for this procedure without imaging guidance, first lesion, effective since the CPT restructure of January 1, 2019.

That restructure replaced a single, familiar code with ten, and many practices are still billing the old way years later. FNA billing generates more coding errors than most other outpatient procedures in dermatology and endocrinology. Getting it right means knowing exactly when 10021 applies, how it pairs with add-on codes, and what documentation satisfies payer review — all covered below.

The sections below address the official descriptor, clinical criteria, the full related code family, reimbursement data, modifier usage, and the most common reasons claims get denied.

CPT code 10021: Description and clinical context

The official AMA CPT code set descriptor for CPT code 10021 reads: Fine needle aspiration biopsy, without imaging guidance; first lesion. This language replaced the older descriptor (“Fine needle aspiration; without imaging guidance”) effective January 1, 2019.

Two changes matter here: the addition of “biopsy” clarifies clinical intent, and “first lesion” establishes that the code covers a single lesion per unit.

In practice, the procedure involves inserting a thin hollow needle into a palpable mass or cyst to aspirate cells or fluid for cytopathologic analysis. No radiologic, fluoroscopic, CT, or MRI guidance is used during the procedure. The specimen goes to pathology for evaluation.

Common clinical settings include thyroid nodule assessment, lymph node sampling, breast mass evaluation, salivary gland lesions, and soft tissue masses. Thyroid nodule assessment is the single most frequent use case, which makes 10021 effectively the default thyroid biopsy CPT code whenever no ultrasound guidance is involved.

For clinics that also handle dermatology EMR software, FNA is a frequent procedure code alongside skin biopsy and lesion removal codes. Understanding where 10021 ends and the imaging-guided codes begin is what separates clean claims from preventable denials.

What qualifies as “without imaging guidance”

A procedure qualifies for 10021 when no imaging modality was used to guide needle placement. The key documentation point: if ultrasound was used only for pre-procedure localization, and not in real time during the aspiration, most payers still classify this as without imaging guidance.

If real-time imaging was used but permanent images were not saved, the correct code is still 10021, not 10005-10012, according to CMS guidance.

Permanent image documentation is the deciding factor. No saved images of guidance = 10021. Real-time guidance with saved images = 10005 or higher depending on modality.

Real-time ultrasound guidance billed separately under CPT 76942 is a different service. It covers image-guided needle placement generally, not FNA specifically, and should not be confused with the 10005-10012 series.

The 2019 coding changes that restructured FNA billing

Before January 1, 2019, the FNA code family had two members: 10021 (without imaging guidance) and 10022 (with imaging guidance). CPT 10022 was deleted entirely on that date. In its place, the AMA CPT Editorial Panel introduced nine new codes, 10004 through 10012, covering FNA by imaging modality and lesion count.

The descriptor for 10021 itself was revised to specify “first lesion,” which made clear that reporting it for a second lesion in the same encounter requires a separate add-on code. Practices that had been using 10021 for every FNA regardless of guidance now needed to distinguish by modality and lesion count on every claim.

Valuation changed too. CMS established the payment value for CPT 10021 by crosswalk to CPT 36440 (push transfusion under 2 years of age), a decision the Endocrine Society formally challenged in February 2019 as undervaluing the clinical work involved. That crosswalk still affects how Medicare reimburses the code today.

Fine needle aspiration CPT code family: 10004-10012

Every FNA claim starts with identifying the correct primary code based on two variables: imaging guidance used and lesion count. The table below covers the full range, per the AAPC Codify CPT lookup.

Add-on codes (10004, 10006, 10008, 10010, 10012) are never reported alone. Each requires a corresponding primary code for the first lesion. All codes in this family are reported once per lesion in a single session, regardless of how many needle passes were made.

None of these codes apply to an open or incisional biopsy. If the physician makes a surgical incision to remove thyroid tissue rather than aspirating it through a needle, the correct code is CPT 60100 (biopsy of thyroid gland, incisional), not any code in the 10004-10012 family.

For comparison, IVF CPT codes follow a similar lesion-specific and modality-specific billing logic, making the 10021 framework a useful model for coders working across procedural specialties.

Documentation requirements for CPT 10021 claims

Clean claims for 10021 start with documentation that confirms three things: the procedure was performed, imaging was not used, and the lesion count matches the codes billed.

A compliant procedure note should include:

• Lesion identification: site, laterality, size, and clinical presentation (palpable mass, cyst, nodule)
• No imaging guidance statement: explicitly note that no real-time imaging was used and no permanent guidance images were obtained
• Needle specification: gauge and type of needle used, number of passes (for clinical context, not for billing units)
• Aspirate description: fluid, cells, or tissue obtained and sent for cytopathology
• Physician attestation: performing provider’s name, credentials, and date of service
• Diagnosis linkage: ICD-10-CM code that establishes medical necessity (e.g., thyroid nodule, lymphadenopathy, soft tissue mass)

The unit-of-service rule applies here as it does across procedural codes: CMS defines the billable unit as the lesion, not the number of passes or specimens. A provider who makes four passes on a single thyroid nodule still bills one unit of 10021.

Practices using digital intake forms can embed procedure documentation templates directly into the patient encounter workflow, reducing the risk of missing required fields before a claim is submitted. Linking the procedure note to the claim form at the point of care is faster than chasing documentation after the fact.

Pathology add-on codes that pair with 10021

The aspiration itself is captured by 10021. The cytopathologic analysis of the specimen is billed separately under pathology codes. Commonly reported alongside 10021:

• 88172: Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis
• 88173: Cytopathology, evaluation of fine needle aspirate; interpretation and report
• 88177: Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, each separate additional evaluation episode

These pathology codes are separately billable and are not bundled with 10021 under NCCI edits, provided the pathologist and performing physician are billed appropriately.

CPT code 10021 vs. CPT code 10005: When imaging guidance changes the code

The most common code selection error in FNA billing is using 10021 when ultrasound guidance was actually employed. CPT 10005 describes FNA with ultrasound guidance for the first lesion and should be used whenever:

• Ultrasound was used in real time to guide needle placement
• Permanent images of the guidance were documented and saved
• The procedure note references imaging findings that directed needle positioning

Billing 10021 when 10005 applies is an undercoding error that leaves reimbursement on the table. 10005 carries higher RVU values because it bundles the guidance work into the code. Billing 10005 when 10021 applies is overcoding, which creates audit risk.

A similar code-selection logic applies in other specialties. Situational anxiety ICD-10 codes follow a comparable decision tree where specificity of the documented clinical finding determines which code is correct, not the provider’s general impression.

For practices that perform both palpation-guided and ultrasound-guided FNAs, building a clear decision tree into the procedure code fee schedule review process prevents systematic undercoding or overcoding across an entire session’s claims.

Stop losing revenue to preventable FNA billing errors

Pabau's claims management software tracks procedure codes, flags documentation gaps before submission, and keeps your FNA billing workflows audit-ready.

Book a demo

CPT code 10021 reimbursement: Rates and the Medicare fee schedule

Reimbursement for 10021 varies by payer, locality, and facility versus non-facility setting. The FastRVU 2026 lookup tool provides current RVU values and geographic adjustment factors for Medicare, a fast way to check RVU by CPT code before submitting a claim.

Under the Medicare Physician Fee Schedule, 10021 carries a relatively modest payment reflecting its crosswalk valuation to CPT 36440. The Endocrine Society argued in 2019 that this crosswalk undervalues the procedure, particularly for thyroid FNA performed by endocrinologists and radiologists. As of publication, the crosswalk value remains the basis for Medicare payment.

Key reimbursement considerations for 10021:

• Facility vs. non-facility: Payment differs depending on whether the procedure is performed in a physician office or hospital outpatient setting. The non-facility rate applies when the physician bears the overhead costs.
• Geographic adjustment: Medicare payment varies by locality through the Geographic Practice Cost Index (GPCI). Use the CMS Physician Fee Schedule search tool for locality-specific rates.
• OPPS/ASC settings: Under the Outpatient Prospective Payment System, 10021 is assigned an Ambulatory Payment Classification (APC). Hospital outpatient billing follows OPPS rates rather than MPFS rates.
• Commercial payers: Typically reimburse at a multiple of Medicare rates or via contracted fee schedules. Verify with each payer’s portal or contract terms.

For exact current dollar amounts, use the PGM Billing CPT lookup to pull current CMS fee schedule data by locality and service setting.

Modifier usage for CPT code 10021

Modifiers clarify billing circumstances that the base code doesn’t capture. For 10021, these apply most frequently:

• Modifier 59 (Distinct procedural service): Use when 10021 is billed on the same date as another procedure that shares an NCCI bundle with it. Modifier 59 signals that the FNA was a separate, distinct service. Verify the NCCI edit before applying.
• Modifier LT / RT (Left / Right): Required by many payers when the procedure involves bilateral structures (e.g., bilateral neck lymph nodes). LT = left side, RT = right side. Apply to each applicable claim line.
• Modifier 50 (Bilateral procedure): Used by some payers in place of LT/RT. Check payer-specific policy before defaulting to either approach, as some payers accept 50 but deny LT/RT and vice versa.
• Modifier 76 (Repeat procedure, same physician): Applicable when the same provider performs FNA on the same lesion on the same date in a repeat session, though this scenario is uncommon.
• Modifier 26 (Professional component): Used when the physician provides the professional interpretation separately from a facility that bills for the technical component. Not typical for office-based FNA but relevant in split-billing hospital arrangements.

Modifier errors are among the top denial reasons for FNA claims. Applying modifier 59 to bypass a legitimate bundle edit, for example, triggers prepayment review. Use modifiers only when the clinical circumstances genuinely support them.

Practices managing multi-provider or multi-location billing will find that consistent modifier policies, documented in a coding policy manual and accessible through their claims management software, reduce claim variability and audit exposure.

Common billing errors and denial prevention for CPT 10021

Most CPT 10021 denials trace back to one of five predictable errors. Fixing them upstream, at the documentation and coding review stage, eliminates the majority of rework.

• Billing 10021 for imaging-guided procedures: If ultrasound was used in real time and images were saved, the correct code is 10005, not 10021. This is the most common overcoding error for thyroid FNA.
• Reporting multiple units of 10021: The unit of service is the lesion. Two lesions = 10021 (first) + 10004 (second). Never report 10021 with more than one unit.
• Missing diagnosis linkage: FNA claims without a supporting ICD-10-CM code establishing medical necessity are denied outright. The most common supporting diagnoses include thyroid nodule (E04.1), lymphadenopathy (R59.9), and unspecified soft tissue mass (M79.9). Document the specific finding that prompted the FNA.
• Using deleted code 10022: Claims submitted with 10022 are automatically rejected. Any superbill, charge master, or EHR template that still lists 10022 must be updated. It has not been a valid code since January 1, 2019.
• Incorrect facility billing: Facility claims for FNA use a different fee schedule than physician office claims. Billing MPFS rates in an OPPS setting, or vice versa, results in payment at the wrong rate or an outright denial.

Keeping patient records tied directly to procedure codes in real time, rather than coding from memory after the encounter, eliminates most of these errors before a claim is ever submitted.

Practices with compliance obligations should also review how their FNA documentation intersects with HIPAA compliance for medical offices, particularly around pathology specimen handling and lab result communication in the patient record.

For coding reference, the ICD-10 diagnostic codes that pair with procedural CPT codes like 10021 follow the same specificity rules: the more precisely the diagnosis is documented, the more defensible the claim.

Conclusion

CPT code 10021 is narrow in scope but common in practice. The 2019 restructure made accurate code selection dependent on two clinical facts that must be documented in every note: whether imaging guidance was used, and how many lesions were sampled.

Get those two right, pair with the correct add-on and pathology codes, and apply modifiers only where genuinely warranted. Most FNA claims will then pass on first submission.

Pabau’s claims management software connects procedure documentation directly to the billing workflow, helping practices flag undercoding, overcoding, and missing diagnosis linkages before submission. To see how it works in a live clinic environment, book a demo.

Continue your research

Need a broader CPT reference for procedure billing? Coaching CPT codes covers the procedural billing framework for another growing specialty, useful context for practices billing across multiple service lines.

Managing billing compliance across multiple payers? HIPAA compliance for medical offices outlines the documentation and data handling standards that support clean claims and audit readiness.

Working with diagnostic codes alongside CPT billing? ICD-10 diagnostic code reference explains how diagnosis specificity affects claim adjudication when paired with procedural codes.

Frequently asked questions